Key result
Intracoronary injection of negative inotropic agents induced dose-dependent ST-segment elevation associated with a parallel reduction in systolic shortening and increase in systolic bulging.
Why the study?
Does regional ventricular dyskinesia induced by negative inotropic agents cause ST-segment elevation in the absence of myocardial ischemia in canine hearts?
Population
33 anesthetized open-chest mongrel dogs of either sex weighing 15-25 kg
Comparison
Intracoronary injection of negative inotropic… vs Intracoronary injection of nitroglycerin or…
Design
Preclinical
Follow-up
Acute
Authors
Loading...
ST elevation may reflect dyskinesia without ischemia in canines; leaves open human relevance and requires clinical validation.
Does regional ventricular dyskinesia induced by negative inotropic agents cause ST-segment elevation in the absence of myocardial ischemia in canine hearts?
Regional ventricular dyskinesia (systolic bulging) can directly cause ST-segment elevation in the absence of myocardial ischemia, suggesting ST-segment elevation is not always a specific marker for acute ischemia.
Shimada et al. (1999) studied Regional ventricular dyskinesia and ST-segment elevation (n=33). Negative inotropic agents (lidocaine, nicorandil, propranolol, or verapamil) was evaluated on ST-segment elevation and regional myocardial contraction (% systolic shortening and % systolic bulging). Intracoronary injection of negative inotropic agents induced dose-dependent ST-segment elevation associated with a parallel reduction in systolic shortening and increase in systolic bulging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: